The goal of this study is to assess response to kisspeptin as well as the baseline patterns of luteinizing hormone (LH) secretion in individuals with polycystic ovarian syndrome (PCOS).
Assignment: All study subjects will undergo the same interventions. Baseline LH secretion patterns of individuals with PCOS will be compared to their LH secretion patterns while receiving a kisspeptin infusion. Delivery of Interventions: * Prior to the inpatient study visit, the subjects will undergo a review of their medical history, physical exam, and screening laboratories. * On the day of the study, the subjects will have an intravenous (IV) line placed and * Undergo up to q10 min blood sampling x 36 hours * Receive an infusion of kisspeptin x 24 hours * Receive up to two kisspeptin IV boluses
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
8
IV infusion of kisspeptin 112-121 x 24 hours; up to two IV boluses of kisspeptin
Massachusetts General Hospital
Boston, Massachusetts, United States
Average change in LH pulse frequency
Average change in LH pulse frequency before and during kisspeptin infusion
Time frame: 6 hours prior to kisspeptin infusion compared to the final 6 hours of kisspeptin infusion
Average change in LH pulse amplitude
Average change in LH pulse amplitude before and during kisspeptin infusion
Time frame: 6 hours prior to kisspeptin infusion compared to the final 6 hours of kisspeptin infusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.